Stöhr M, Fischinger W
Arzneimittelforschung. 1978;28(6):977-81.
The effects of the antitumor agents vincristine (VCR) and vincaleucoblastine (VLB) on the cell cycle progression of three different ascites tumor cell lines in vivo (Ehrlich, Crocker S 180, and leukemia L 1210) were studied in detail by flow microfluorometric techniques over a 5-day period of drug treatment and during the post-treatment course. These investigations give evidence that the tumor lines employed show completely different sensitivity against VCR and VLB. During the treatment massive polyploidization was demonstrated to be, in general, the second response of treated cells overcoming an initial proliferative block in the G 2 phase of their life cycle.
通过流式细胞荧光测定技术,在为期5天的药物治疗期间及治疗后的过程中,详细研究了抗肿瘤药物长春新碱(VCR)和长春碱(VLB)对三种不同腹水肿瘤细胞系(艾氏腹水癌、克罗克S180和白血病L1210)体内细胞周期进程的影响。这些研究表明,所采用的肿瘤细胞系对VCR和VLB表现出完全不同的敏感性。在治疗过程中,大量多倍体化通常被证明是被治疗细胞的第二种反应,克服了其生命周期G2期最初的增殖阻滞。